News

On Friday evening, December 18, 2020 the United States Food & Drug Administration (FDA) approved Moderna’s mRNA Covid-19 vaccine for emergency use, joining Pfizer’s previously approved ...
Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...
BUT THE FDA IS NOW SAYING IT MAY RAISE THE RISK OF CANCER. HERE TO TALK ABOUT THIS IS DOCTOR ANDREAS KLEIN, THE INTERIM CHAIR OF HEMATOLOGY ONCOLOGY AT TUFTS MEDICAL CENTER. GREAT. GREAT TO SEE ...
Pfizer is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years.Shares are down 19% over the past ...
RFK Jr. previously said he wants to phase out petroleum-based dyes. The U.S. Food and Drug Administration (FDA) approved on Friday additional color additives from natural sources in line with the ...
The recent decision by Congress to eliminate funding for the Multiple Sclerosis Research Program (MSRP) in the FY 2025 budget is a devastating setback for those of us living with MS. The program ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) is planning to host its first meeting under new agency commissioner Marty Makary, M.D. As head of the FDA’s oncology department, Richard ...
The meetings appear to be part of a broader effort at the FDA to use this technology to speed up the drug approval process. “Why does it take over 10 years for a new drug to come to market?” ...
Languages: English and French. A salsa product recalled in April has now been issued a Class II risk classification by the U.S. Food and Drug Administration (FDA). MegaMex Foods LLC, based in ...
Novo Nordisk A/S NVO slashed its 2025 sales forecast Wednesday, citing lower-than-expected penetration of its branded GLP-1 weight loss and diabetes treatments in the U.S. market due to ...
Five weeks after Peter Marks suddenly resigned as director of the FDA’s Center for Biologics Evaluation and Research, the division has a new boss. Tuesday, FDA Commissioner Marty Makary named Vinay ...
the past few weeks have seem one small victory and a huge setback for some of the big players in the field. Amid profits updates and shareholder news, Pfizer released a statement titled "Pfizer ...